Gene editing enables T-cell engineering to redirect antigen specificity for potent tumor rejection

Adoptive transfer of TCR transgenic T cells holds great promise for treating various cancers. So far, mainly semi-randomly integrating vectors have been used to genetically modify T cells. These carry the risk of insertional mutagenesis, and the sole addition of an exogenous TCR potentially results...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Life Sci Alliance
Main Authors: Albers, Julian J, Ammon, Tim, Gosmann, Dario, Audehm, Stefan, Thoene, Silvia, Winter, Christof, Secci, Ramona, Wolf, Anja, Stelzl, Anja, Steiger, Katja, Ruland, Jürgen, Bassermann, Florian, Kupatt, Christian, Anton, Martina, Krackhardt, Angela M
Formato: Artigo
Idioma:Inglês
Publicado em: Life Science Alliance LLC 2019
Assuntos:
Resources
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6421629/
https://ncbi.nlm.nih.gov/pubmed/30877233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.26508/lsa.201900367
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados